Oddo BHF Asset Management Sas Buys New Stake in Humana Inc. (NYSE:HUM)

Oddo BHF Asset Management Sas bought a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 4,122 shares of the insurance provider's stock, valued at approximately $1,306,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. PDT Partners LLC grew its position in Humana by 190.0% in the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after acquiring an additional 2,660 shares during the last quarter. Ontario Teachers Pension Plan Board boosted its stake in shares of Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock valued at $371,705,000 after purchasing an additional 71,910 shares during the period. Swedbank AB grew its holdings in shares of Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider's stock worth $33,567,000 after purchasing an additional 3,085 shares during the last quarter. Heritage Oak Wealth Advisors LLC purchased a new position in Humana in the 2nd quarter worth about $3,456,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Humana by 3.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider's stock valued at $284,810,000 after buying an additional 26,056 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Up 0.5 %

Shares of HUM traded up $1.34 during mid-day trading on Friday, hitting $274.12. 1,383,466 shares of the company traded hands, compared to its average volume of 1,841,710. The company has a market capitalization of $33.01 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 2.15 and a beta of 0.53. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The business has a 50 day moving average of $274.13 and a 200 day moving average of $324.70. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $486.00.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Equities research analysts anticipate that Humana Inc. will post 16.14 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.29%. Humana's payout ratio is presently 31.36%.

Analysts Set New Price Targets

A number of brokerages have commented on HUM. Barclays upped their target price on shares of Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 31st. Sanford C. Bernstein upgraded Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. KeyCorp initiated coverage on Humana in a research report on Friday, October 11th. They set a "sector weight" rating for the company. Bank of America raised Humana from an "underperform" rating to a "neutral" rating and increased their price target for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada decreased their price objective on Humana from $400.00 to $265.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $304.15.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.